HOME
SEARCH
RSS FEED
SUBSCRIBE
Search Results - robert+hodges
4
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Antimicrobial Peptides to Treat Gram-negative infections
The growing emergence of pathogenic bacteria with clinical significant resistance to conventional antibiotics is a major public health concern. There has been a revival of polymyxins which have serious issues of nephrotoxicity/ neurotoxicity as antibiotics of last resort. Resistance to polymyxins means that no antibiotics are available for the treatment...
Published: 5/7/2023
|
Inventor(s):
Robert Hodges
,
Colin Mant
,
Lajos Gera
,
Ziqing Jiang
Disease Areas
Category(s):
Therapeutics
Novel Compounds Show Promise in Treating Variety of Cancers
A group of researchers led by Lajos Gera and
Robert Hodges
has developed two sets of compounds: flurbiprofen analogs and silylalkyloxyaryl amino acid analog compounds that have proven to be effective against a wide variety of cancer cell lines. Both were screened using the NCI-60 cell lines, a panel of 60 diverse human cancer cell lines used by National...
Published: 5/7/2023
|
Inventor(s):
Lajos Gera
,
Robert Hodges
,
Peter Hegyes
,
Daniel Muruve
Disease Areas
Oncology
Category(s):
Therapeutics
Targeting Claudins to Enhance Apoptic Response of Cancer Cells
Dr. Margaret Neville and her research team have developed a novel peptide that targets and disrupts claudins, a family of tight junction proteins. Dr. Neville has shown that disruption of claudins initiates a cellular signaling cascade that activates the death receptor pathway causing apoptosis of epithelial cells. This disruption caused a seven-fold...
Published: 11/30/2023
|
Inventor(s):
Margaret Neville
,
Robert Hodges
,
Neal Beeman
Disease Areas
Oncology
Category(s):
Therapeutics
Novel Compounds Show Promise in Treating Variety of Cancers
A group of researchers led by Lajos Gera and
Robert Hodges
has developed two sets of compounds: flurbiprofen analogs and silylalkyloxyaryl amino acid analog compounds that have proven to be effective against a wide variety of cancer cell lines. Both were screened using the NCI-60 cell lines, a panel of 60 diverse human cancer cell lines used by National...
Published: 5/21/2023
|
Inventor(s):
Lajos Gera
,
Daniel Chuen-Fong Chan
,
Robert Hodges
,
Paul Bunn
Disease Areas
Oncology
Category(s):
Therapeutics
Home
|
Search
|
RSS
|
Subscribe
For inquiries, email: cuinnovations@cuanschutz.edu. © 2024. All Rights Reserved. Powered by
Inteum